Brighter strengthens IP portfolio with 3 new patents in Sweden and South Korea.
Brighter's IP portfolio has been expanded with 3 new patents - two in Sweden and one in South Korea. The patents are related to AI monitoring of connected medical devices and skin patch technology for measuring different biomarkers.
For further information, please contact:
Truls Sjöstedt, Executive Chairman of the Board
Telephone: +46 729 99 38 60
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/
The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, firstname.lastname@example.org, www.eminova.se.